Literature DB >> 11444472

Antisecretory effect of loperamide in colon epithelial cells by inhibition of basolateral K+ conductance.

H J Epple1, M Fromm, E O Riecken, J D Schulzke.   

Abstract

BACKGROUND: The mechanism of the antisecretory effect of loperamide was investigated in cultured highly differentiated colon epithelial cells (HT-29/B6).
METHODS: Chloride secretion was stimulated via cAMP by forskolin (FSK, 10(-5) M), via Ca2+ by the muscarinic agonist carbachol (CCh, 10(-4) M), and via protein kinase C by the phorbol ester PMA (5 x 10(-9) M). Stimulated Cl- secretion was quantified as short circuit current (I(SC)) of HT-29/B6 monolayers mounted in Ussing-type chambers.
RESULTS: Loperamide (5 x 10(-5) M) inhibited I(SC) stimulated by FSK, CCh and PMA. The antisecretory action of loperamide was unaffected by preincubation with naloxone (10(-5) M). Furthermore, loperamide strongly inhibited basolateral 86Rb efflux. Like loperamide, the calmodulin antagonist trifluoperazine (10(-4) M) inhibited I(SC) induced by FSK, CCh or PMA. The Ca2+ channel blocker verapamil (5 x 10(-5) M), on the other hand, inhibited only PMA-stimulated I(SC),but had no effect on FSK or CCh-induced I(SC)
CONCLUSIONS: Loperamide exerts a direct antisecretory action on chloride secretion of colon epithelial cells independently of the respective stimulatory signal transduction pathway. This antisecretory effect is not mediated by opiate receptors and reflects inhibition of basolateral K+ conductance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444472     DOI: 10.1080/003655201300191996

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  6 in total

Review 1.  Function of K+ channels in the intestinal epithelium.

Authors:  R Warth; J Barhanin
Journal:  J Membr Biol       Date:  2003-05-15       Impact factor: 1.843

2.  Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome.

Authors:  Marta Zielińska; Agata Jarmuż; Andrzej Wasilewski; Gerta Cami-Kobeci; Stephen Husbands; Jakub Fichna
Journal:  Pharmacol Rep       Date:  2016-12-05       Impact factor: 3.024

Review 3.  Neratinib in HER-2-positive breast cancer: results to date and clinical usefulness.

Authors:  Arlene Chan
Journal:  Ther Adv Med Oncol       Date:  2016-07-10       Impact factor: 8.168

Review 4.  Intestinal secretory mechanisms and diarrhea.

Authors:  Stephen J Keely; Kim E Barrett
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-02-16       Impact factor: 4.052

5.  Aeromonas hydrophila beta-hemolysin induces active chloride secretion in colon epithelial cells (HT-29/B6).

Authors:  H J Epple; J Mankertz; R Ignatius; O Liesenfeld; M Fromm; M Zeitz; T Chakraborty; J D Schulzke
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

Review 6.  Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report.

Authors:  Mark S Riddle; Bradley A Connor; Nicholas J Beeching; Herbert L DuPont; Davidson H Hamer; Phyllis Kozarsky; Michael Libman; Robert Steffen; David Taylor; David R Tribble; Jordi Vila; Philipp Zanger; Charles D Ericsson
Journal:  J Travel Med       Date:  2017-04-01       Impact factor: 8.490

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.